An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

Trial Profile

An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

Discontinued
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2017

At a glance

  • Drugs Secukinumab (Primary)
  • Indications Alopecia areata
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jan 2017 Status changed from recruiting to discontinued due to low enrollment.
    • 19 Jan 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
    • 09 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top